A comparison of treatment planning techniques for low-dose-rate (LDR) prostate brachytherapy

被引:2
|
作者
Connolly, David [1 ,2 ]
Sands, Gordon [3 ]
Winter, Helen [3 ]
Foley, Mark J. [1 ]
Kleefeld, Christoph [1 ]
机构
[1] Natl Univ Ireland Galway, Sch Phys, Univ Rd, Galway, Ireland
[2] Cork Univ Hosp, Dept Med Phys, Cork, Ireland
[3] Oxford Univ Hosp NHS Fdn Trust, Radiotherapy Dept, Oxford, England
关键词
LDR; Prostate brachytherapy; Treatment planning; 4D Brachytherapy; TRUS; MRI;
D O I
10.1016/j.brachy.2020.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: The purpose of this study was to compare low-dose-rate prostate brachytherapy treatment plans created using three retrospectively applied planning techniques with plans delivered to patients. METHODS AND MATERIALS: Treatment plans were created retrospectively on transrectal ultrasound (TRUS) scans for 26 patients. The technique dubbed 4D Brachytherapy was applied, using TRUS and MRI to obtain prostatic measurements required for the associated webBXT online nomogram. Using a patient's MRI scan to create a treatment plan involving loose seeds was also explored. Plans delivered to patients were made using an intraoperative loose seed TRUS-based planning technique. Prostate V-100 (%), prostate V-150 (%), prostate D-90 (Gy), rectum D-0.1cc (Gy), rectum D(2c)c (Gy), urethra D-10 (%), urethra D-30 (%), and prostate volumes were measured for each patient. Statistical analysis was used to assess and compare plans. RESULTS: Prostate volumes measured by TRUS and MRI were significantly different. Prostate volumes calculated by the webBXT online nomogram using TRUS- and MRI-based measurements were not significantly different. Compared with delivered plans, TRUS-based 4D Brachytherapy plans showed significantly lower rectum D-0.1cc (Gy) values, MRI-based 4D Brachytherapy plans showed significantly higher prostate V-100 (%) values and significantly lower rectum D-0.1cc (Gy), urethra D-10 (%), and urethra D-30 (%) values, and loose seed MRI-based plans showed significantly lower prostate V-100 (%), prostate D-90 (Gy), rectum D-0.1cc (Gy), rectum D-2cc (Gy), urethra D-10 (%), and urethra D-30 (%) values. CONCLUSIONS: TRUS-based 4D Brachytherapy plans showed similar dosimetry to delivered plans; rectal dosimetry was superior. MRI can be integrated into the 4D Brachytherapy workflow. The webBXT online nomogram overestimates the required number of seeds. (C) 2020 The Authors. Published by Elsevier Inc.
引用
收藏
页码:410 / 419
页数:10
相关论文
共 50 条
  • [41] Patient-reported outcome measures following focal low-dose-rate (LDR) brachytherapy for intermediate risk prostate cancer
    Harkin, Timothy
    Smyth, Lloyd
    Anderson, Elliot
    O'Sullivan, Richard
    Ryan, Andrew
    Lawrentschuk, Nathan
    Katz, Darren
    Grummet, Jeremy
    See, Andrew
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 82 - 83
  • [42] Low-Dose-Rate Brachytherapy for Treatment of Uterine Didelphys Malignancy
    Kunos, Charles
    Woods, Charles
    Colussi, Valdir C.
    Abdul-Karim, Fadi W.
    Waggoner, Steven
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) : E104 - E106
  • [43] Comparison of Intraoperative and Postoperative Dosimetric Parameters for the Urethra and Prostate in Patients Undergoing Low-Dose-Rate Prostate Brachytherapy
    Algan, O.
    Nicholas, Z.
    Ali, I.
    Sindhwani, P.
    Ahmad, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S380 - S381
  • [44] Treatment Outcome of Medium-Dose-Rate Intracavitary Brachytherapy for Carcinoma of the Uterine Cervix: Comparison With Low-Dose-Rate Intracavitary Brachytherapy
    Kaneyasu, Yuko
    Kita, Midori
    Okawa, Tomohiko
    Maebayashi, Katsuya
    Kohno, Mari
    Sonoda, Tatsuo
    Hirabayashi, Hisae
    Nagata, Yasushi
    Mitsuhashi, Norio
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (01): : 137 - 145
  • [45] Embedding expertise knowledge into inverse treatment planning for low-dose-rate brachytherapy of hepatic malignancies
    Zhu, Jianjun
    Wang, Cheng
    Teng, Sitong
    Lu, Jian
    Lyu, Pengju
    Zhang, Pujun
    Xu, Jun
    Lu, Ligong
    Teng, Gao-Jun
    [J]. MEDICAL PHYSICS, 2024, 51 (01) : 348 - 362
  • [46] Low-dose-rate brachytherapy for prostate cancer: Preplanning vs. intraoperative planning-Intraoperative planning is best
    Zelefsky, Michael J.
    Zaider, Marco
    [J]. BRACHYTHERAPY, 2006, 5 (03) : 143 - 144
  • [47] TRIFECTA OUTCOMES FOR MEN WITH LOCALIZED PROSTATE CANCER AFTER TREATMENT WITH LOW-DOSE-RATE BRACHYTHERAPY
    Kent, Marissa
    Winoker, Jared
    Stock, Richard
    Stone, Nelson
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E278 - E279
  • [48] Comparison of three different techniques of low-dose-rate seed implantation for prostate cancer
    Ishiyama, Hiromichi
    Satoh, Takefumi
    Sekiguchi, Akane
    Tabata, Ken-ichi
    Komori, Shouko
    Tsumura, Hideyasu
    Kawakami, Shogo
    Soda, Itaru
    Takenaka, Kouji
    Lwamura, Masatsugu
    Hayakawa, Kazushige
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2015, 7 (01) : 3 - 9
  • [49] Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma
    Yamoah, Kosj
    Eldredge-Hindy, Harriet B.
    Zaorsky, Nicholas G.
    Palmer, Joshua D.
    Doyle, Laura A.
    Sendecki, Jocelyn A.
    Hesney, Adam A.
    Harper, Logan
    Repka, Michael
    Showalter, Timothy N.
    Hurwitz, Mark D.
    Dicker, Adam P.
    Den, Robert B.
    [J]. BRACHYTHERAPY, 2014, 13 (05) : 456 - 464
  • [50] Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost
    Kollmeier, Marisa A.
    Gorovets, Daniel
    Flynn, Jessica
    McBride, Sean
    Brennan, Victoria
    Beaudry, Joel
    Cohen, Gilad
    Damato, Antonio
    Zhang, Zhigang
    Zelefsky, Michael J.
    [J]. BRACHYTHERAPY, 2022, 21 (05) : 599 - 604